Molecule synthetization fo healthcare
M2i Life Sciences has raised €6.8M across 1 funding round, most recently a round in Jul 2017. Based in France; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-07-17 | Other | €6.8M |
| — |
| View deal → |
